Keywords: Functional Technologies, Malaria treatment, Yeast-based approach

Canada’s Functional Technologies reports positive preclinical results of novel, yeast-based malaria treatment

Article | 06 September 2010

Print This

In a second announcement last week of developments in the fight against malaria, Canadian firm Functional Technologies (TSX-V: FEB), in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in